| Date Filed | Type | Description |
| 10/13/2023 |
PREC14A
| Form PREC14A - Preliminary proxy statements, contested solicitations: |
| 10/10/2023 |
PREC14A
| Form PREC14A - Preliminary proxy statements, contested solicitations: |
| 09/29/2023 |
4
| Equels Thomas K (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Bought 22,676 shares
@ $0.441, valued at
$10k
|
|
| 09/29/2023 |
8-K
| Quarterly results |
| 08/25/2023 |
4
| Equels Thomas K (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Bought 8,222 shares
@ $0.669, valued at
$5.5k
|
|
| 08/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/23/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 08/15/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/07/2023 |
SC 13D/A
| Deutsch Todd reports a 3.5% stake in AIM IMMUNOTECH INC. |
| 07/27/2023 |
SC 13D
| Deutsch Todd reports a 3.5% stake in AIM IMMUNOTECH INC. |
| 07/17/2023 |
4
| Equels Thomas K (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Bought 16,950 shares
@ $0.59, valued at
$10k
|
|
| 07/10/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 07/03/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/12/2023 |
8-A12B/A
| Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] |
| 04/19/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 04/19/2023 |
8-K
| Quarterly results |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/30/2023 |
8-K
| Quarterly results |
| 03/16/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 03/13/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 03/10/2023 |
4
| APPELROUTH STEWART (Director) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Disposed of 68,208 shares
@ $1.23, valued at
$83.9k
Acquired 143 options to buy
@ $0
Acquired 150 options to buy
@ $0
Acquired 163 options to buy
@ $0
Acquired 196 options to buy
@ $0
Acquired 250 options to buy
@ $0
Acquired 287 options to buy
@ $0
Acquired 295 options to buy
@ $0
Acquired 338 options to buy
@ $0
Acquired 2,568 options to buy
@ $0
Acquired 1,136 options to buy
@ $0 |
|
| 03/08/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 03/06/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 02/24/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 02/10/2023 |
8-K
| Quarterly results |
| 02/10/2023 |
8-A12B/A
| Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] |
| 02/06/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 01/17/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 01/04/2023 |
4
| APPELROUTH STEWART (Director) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Bought 80,646 shares
@ $0.31, valued at
$25k
|
|
| 01/04/2023 |
4
| Equels Thomas K (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Bought 161,291 shares
@ $0.31, valued at
$50k
|
|
| 01/04/2023 |
4
| Rodino Peter W III (COO, Secretary, Gen. Counsel) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Bought 80,646 shares
@ $0.31, valued at
$25k
|
|
| 01/03/2023 |
4
| LINTAL ELLEN M (Former Chief Financial Officer) has filed a Form 4 on AIM ImmunoTech Inc. |
|